Special Issue "Medicine Use in Upper Respiratory Airways and Asthma"

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 31 May 2020.

Special Issue Editors

Dr. Sinthia Bosnic-Anticevich
Website
Guest Editor
University of Sydney, Woolcock Institute of Medical Research, Sydney Local Health District, Sydney, NSW, Australia
Interests: quality use of respiratory medicines; inhaler technique; primary care; allergic rhinitis and asthma
Dr. Vicky Kritikos
Website
Guest Editor
University of Sydney, Woolcock Institute of Medical Research, Sydney, Australia
Interests: quality use of respiratory medicines; inhaler technique; primary care; allergic rhinitis and asthma
Ms. Biljana Cvetkovski

Guest Editor
University of Sydney, Woolcock Institute of Medical Research, Sydney, Australia
Interests: quality use of respiratory medicines; inhaler technique; primary care; allergic rhinitis and asthma

Special Issue Information

Dear Colleagues,

Chronic, allergic, airway diseases, specifically asthma and rhinitis, are on the rise worldwide, and represent an enormous health and economic burden to individuals, healthcare systems, and society. When it comes to the management of these conditions, which often coexist, the inappropriate use of medications is a major issue and remains a persistent barrier to achieving optimal patient outcomes. This has been highlighted by the recent Lancet Asthma Commission, calling for effective methods of identifying and addressing non-adherence to inhaled preventative asthma medication, and Allergic Rhinitis and its Impact on Asthma (ARIA) in Pharmacy, identifying the need for delivery of strategies and interventions that address suboptimal rhinitis and asthma control arising from suboptimal treatment.

Pharmacists are trusted healthcare professionals who play an increasingly important role in primary care. They are ideally placed to deliver timely interventions that promote and facilitate the quality use of medicines and support patients in self-management, in view of their therapeutic expertise, accessibility, regular contact with patients and contact with patients who do not visit other healthcare providers regularly. Previous research has shown that pharmacists can improve clinical outcomes in asthma and allergic rhinitis patients with interventions targeting inhaler technique and goal setting. New approaches such as integrated care pathways that focus on the quality and coordination of care and change management, as well as the use of technology, are now being explored.

We invite you to share your approaches to promoting and facilitating the quality use of respiratory medicines either in primary or tertiary care settings. We hope this Special Issue will encourage healthcare researchers to share their strategies and healthcare models that will help achieve and sustain optimal patient outcomes for individuals living with these chronic respiratory conditions.

Prof. Sinthia Bosnic-Anticevich
Dr. Vicky Kritikos
Ms. Biljana Cvetkovski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Asthma
  • Allergic rhinitis
  • Primary care
  • Pharmacy
  • Quality use of respiratory medicines
  • Inhaler technique
  • Adherence
  • Short-acting beta agonists

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

Open AccessArticle
Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
Pharmacy 2020, 8(2), 85; https://doi.org/10.3390/pharmacy8020085 - 16 May 2020
Abstract
The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, [...] Read more.
The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines. Full article
(This article belongs to the Special Issue Medicine Use in Upper Respiratory Airways and Asthma)
Show Figures

Figure 1

Review

Jump to: Research

Open AccessReview
Interventions Delivered in the Community Pharmacy to Manage Allergic Rhinitis- A Systematic Review of the Literature
Pharmacy 2020, 8(2), 80; https://doi.org/10.3390/pharmacy8020080 - 06 May 2020
Abstract
Pharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharmacy level. This role has been reported extensively in numerous papers. However, a systematic review of the available literature and a comprehensive analysis of the outcomes has not [...] Read more.
Pharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharmacy level. This role has been reported extensively in numerous papers. However, a systematic review of the available literature and a comprehensive analysis of the outcomes has not been published. This systematic review aimed to evaluate the impact of interventions developed by pharmacists on clinical AR outcomes. A thorough search was performed in three electronic databases, including studies published between January 2000 and June 2019. After the selection process, only three articles met the inclusion criteria and were further analysed. Despite the scarcity of the available studies, in all of them was clear that the pharmacist plays a pivotal role in the management of AR, significantly improving the patients’ quality of life and symptom control. This systematic review also stresses the utmost importance to investigate and report practices and interventions developed by pharmacists using measurable outcomes. Full article
(This article belongs to the Special Issue Medicine Use in Upper Respiratory Airways and Asthma)
Show Figures

Figure 1

Back to TopTop